Genetic testing in nephrology plays a critical role in understanding the underlying causes of kidney disease, particularly in cases with early onset, familial patterns, or atypical presentation. Many kidney disorders such as diabetes and cystic kidney disease have a genetic basis that can be identified through targeted or comprehensive genetic analysis. Early identification of a genetic cause can improve diagnostic accuracy, guide clinical management, and inform prognosis. It also enables proactive screening of at-risk family members and supports informed family planning. Genetic insights are increasingly essential for tailoring treatment strategies and identifying patients who may benefit from emerging therapies or clinical trials. Nephrology genetic testing is an important step toward more personalised, proactive, and effective kidney care.
Genetic testing for hereditary kidney disease can help you, the healthcare practitioner, to:
Genseq offer 19 nephrology gene panels (see table below). These are in silico panels based on whole exome sequencing (WES) data. All panels include single nucleotide variants (SNV), small insertions/deletions (indels), and copy number variation (CNV) analysis.
NEE1002
5
NEE1003
Atypical Haemolytic Uraemic Syndrome Panel
9
NEE1004
10
NEE1001
Comprehensive Nephrology Panel
330
NEE1005
37
NEE1006
Diabetes Insipidus, Nephrogenic Panel
3
NEE1007
Extreme Early-onset Hypertension Panel
15
NEE1008
Hereditary Systemic Amyloidosis Panel
7
NEE1009
Membranoproliferative Glomerulonephritis including C3 Glomerulopathy Panel
8
NEE1010
Nephrocalcinosis or Nephrolithiasis Panel
35
NEE1011
Proteinuric Renal Disease Panel
57
NEE1012
10
NEE1013
Rare Multisystem Ciliopathy Panel
113
NEE1014
Renal Malformations (CAKUT) Panel
59
NEE1015
293
NEE1016
50
NEE1017
Tubulointerstitial Kidney Disease Panel
20
NEE1018
Unexplained Kidney Failure in Young People
85
NEE1019
Unexplained Young-onset End-stage Renal Disease Panel
259